Effectiveness of a treat-to-target strategy in patients with moderate to severely active rheumatoid arthritis treated with abatacept | Synapse

⌘+K

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α InhibitionRCT · 2005 · 1,247 citations
2Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial2024 · 189 citations
3Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: Twelve‐month results of a phase iib, double‐blind, randomized, placebo‐controlled trialRCT · 2005 · 445 citations
4Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritisRCT · 2017 · 217 citations
5Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factorsPrognostic Study · 2009 · 340 citations
6Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world settingHuman Clinical Trial · 2018 · 32 citations
7The Application of Abatacept in the Treatment of Rheumatoid Arthritis2025
8Effect of abatacept treatment on serum osteoclast-related biomarkers in patients with rheumatoid arthritis (RA)Cohort Study · 2021 · 9 citations
9Immune checkpoint inhibitors in patients with rheumatoid arthritis: a matched cohort study of immune-related adverse events and survivalArthritis Research & Therapy · 2026
10Confirmation of anti-TERF1 autoantibodies in systemic sclerosis and fibrotic lung disease using a novel particle-based immunoassayArthritis Research & Therapy · 2026

More from Arthritis Research & Therapy

More from McGill University